Department of Hepatobiliary Surgery, Clinical Medical College of Yangzhou University, 98 West Nantong Rd, Yangzhou, 225000, China.
Surg Endosc. 2018 Jun;32(6):2696-2703. doi: 10.1007/s00464-017-5965-3. Epub 2017 Nov 3.
Conventional open and conventional laparoscopic splenectomy and azygoportal disconnection (CLSD) result in poor quality of life because of damage to the vagal nerve. We have developed vagus nerve-preserving laparoscopic splenectomy and azygoportal disconnection (VLSD). This study aimed to evaluate whether VLSD is effective and safe, and to determine whether a reduction in the incidence of postoperative complications improves postoperative quality of life compared with CLSD.
We retrospectively evaluated outcomes in 72 cirrhotic patients with portal hypertensive bleeding and secondary hypersplenism who underwent CLSD (n = 40) or VLSD (n = 32) between April 2015 and December 2016. Their demographic, intraoperative, and postoperative variables were compared.
No patients required conversion to laparotomy in CLSD and VLSD. There was no difference in estimated intraoperative blood loss, volume of intraoperative blood transfused, time to first flatus, time to off-bed activity, and postoperative hospital stay between the two groups. VLSD was associated with a shorter operation time (P = 0.020) and less postoperative complications (P < 0.0001), including less diarrhea (P < 0.0001), epigastric fullness (P < 0.0001), and delayed gastric emptying (P < 0.0001), compared with CLSD. With VLSD, there was a significant increase in body weight and plasma albumin levels at 6 months postoperatively compared with preoperative values (all P < 0.05). The curative effect of improving esophageal/gastric variceal bleeding was similar in the groups.
VLSD is effective and safe for reducing the incidence of postoperative complications, contributing to improving postoperative quality of life.
传统的开腹和腹腔镜脾切除术及门奇静脉断流术(CLSD)会因损伤迷走神经而导致生活质量较差。我们已经开发出了保留迷走神经的腹腔镜脾切除术及门奇静脉断流术(VLSD)。本研究旨在评估 VLSD 是否有效和安全,以及与 CLSD 相比,减少术后并发症的发生率是否能改善术后生活质量。
我们回顾性评估了 2015 年 4 月至 2016 年 12 月期间接受 CLSD(n=40)或 VLSD(n=32)治疗的 72 例肝硬化伴门静脉高压性出血和继发性脾功能亢进患者的结局。比较了他们的人口统计学、术中及术后变量。
CLSD 和 VLSD 均无患者中转开腹。两组间估计术中出血量、术中输血量、首次排气时间、离床活动时间和术后住院时间无差异。VLSD 与较短的手术时间(P=0.020)和较少的术后并发症(P<0.0001)相关,包括腹泻(P<0.0001)、上腹胀满(P<0.0001)和胃排空延迟(P<0.0001)较少。与 CLSD 相比,VLSD 术后 6 个月体重和血浆白蛋白水平明显升高(均 P<0.05)。两组在改善食管/胃静脉曲张出血的疗效方面相似。
VLSD 可有效降低术后并发症发生率,有助于改善术后生活质量。